ADMA Biologics, Inc. (ADMA)
17.31
-0.19
(-1.09%)
USD |
NASDAQ |
Jan 16, 16:00
17.40
+0.09
(+0.52%)
After-Hours: 20:00
ADMA Biologics Shareholders Equity (Quarterly): 431.19M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 158.07M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| Marker Therapeutics, Inc. | 18.39M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 568.69M |
| Total Liabilities (Quarterly) | 137.50M |
| Debt to Equity Ratio | 0.1928 |
| Current Ratio | 7.128 |
| Net Debt Paydown Yield | 0.33% |